(Banner will apear here)

Beautiful Kabbalah Jewelry Judaicawebstore.com

Israeli Technology

New Meds Could Stop Cancer by Cutting Off Its Blood

Researchers at Tel Aviv University are developing a new family of medicines that could provide preventive treatment for cancer, or turn existing cancer into a chronic disease that one can live with for years.


Leukemia 'Miracle' In Israel & OECD

Dr. Archana Jabhav: 'My Son's Recovery From Leukemia In Israel Was No Less Than a Miracle!'

'Hadassah's Bone Marrow Transplant Department Rescued Him From Critical Stage After Other Treatments Failed'

IsraCast Assessment: Successful Treatment Of Critical Leukemia Patient From India Illustrates High Level Of Israeli Medical Research, One Of Numerous Factors Justifying Israel's Acceptance Into OECD

 What is the connection between the acceptance of Israel into the esteemed OECD, the Organization for Economic Co-Operation & Development, and the miraculous recovery of a youngster from India from a critical stage of leukemia? Simply this - it illustrates why the prestigious OECD has now accepted the Jewish state as a deserving member for her record of achievement.


Bar Ilan Institute of Nanotechnology and Advanced Materials

 Research efforts are concentrated within six core areas that were identified when the Bar-Ilan Institute of Nanotechnology & Advanced Materials was established. Each research area has its own dedicated Center within the Institute. The six centers of excellence are: Nano-Materials Center, Nano-Medicine Center, The Dahan Nano-Energy Center, Nano-Magnetism Center, Nano-Cleantech Center and Nano-Photonics Center.


Nanotechnology big time

 This week Bar-Ilan University will dedicate the Multidisciplinary Center for Advanced Materials and Nanotechnology. Just another festive occasion at an academic institution that spotlights, for a brief moment, the work of a group of researchers focused on a specific field of scientific endeavor. One more ceremony at which these researchers are showered with deserved praise, where proper thanks are expressed to donors who have provided us with another essential infrastructure for enriching human knowledge. But the new center’s unique characteristics also provide us with an opportunity to examine several important issues relevant to Israeli science in the 21st century.


Exclusive - Israel-India Joint Cancer Research

Prof. Reuven Or:'Israeli & Indian Researchers Now Collaborating In Field Of Bone Marrow Transplantation'

'I Hope For Joint Project On Natural Killer Cells That Can Effectively Fight Cancer Cells'

'Dr. Grant, My Indian Colleague Is A Giant Of A Doctor, Who Has Recruited Highly Professional Staff At Ruby Hall Clinic In Pune'

 The Bone Marrow Transplantation Department at Hadassah Medical Center in Ein Kerem, Jerusalem has been at the forefront of research and clinical treatment since this field started playing a major role in the treatment of cancer. Its department director, Prof. Reuven Or has just returned from a working visit to India where he gave seminars at three hospitals and participated as a consultant in the opening of the new Bone Marrow Transplantation department at the Ruby Hall Clinic in the Pune urban region. In an exclusive interview with David Essing, Dr. Or also disclosed that more joint projects are now underway.


New Israeli battery provides thousands of hours of power

 A new kind of portable electrochemical battery that can produce thousands of hours of power - and soon replace the expensive regular or rechargeable batteries in hearing aids and sensors and eventually in cellphones, laptop computers and even electric cars - has been developed at Haifa's Technion - Israel Institute of Technology.


Prof. Oded Abramsky - chairman of the National Council for Research and Development

Oded Abramsky was born in Jerusalem. He received M.D. and Ph.D. degrees from the Hebrew University of Jerusalem. He did his residency in Neurology at the Hadassah University Hospital and became Board Certified in Neurology in 1973. In 1981-1988 he was the Chairman of the Division of Neurology and Neurosurgery in the Hebrew University Hadassah Medical School. In 1982 he was appointed Head of the Neuroimmunolgoy Unit at Hadassah Medical Organization, and Professor of Neurology at the Hebrew University of Jerusalem.


Israeli scientist Ada Yonath Wins Nobel Prize

Prof. Ada Yonath of the Weizmann Institute of Science, a leading researcher in the structural biology field, was awarded a Nobel Prize in chemistry.


Exclusive - A New Strategy for Immunotherapy of Cancer

 The best way to prevent and remove infections is through the natural 'sterilising' action of the immune response that combines elements of both innate and adaptive immunity to ward off foreign pathogens without medical intervention. The immune system 'remembers' the cleared foreign antigens to speed up its response to re-infection. The immune system in most cancer patients can still completely destroy viruses and bacteria. The ferocity and specificity of this response can be witnessed in the way an inadequately suppressed immune system can completely destroy a large transplanted organ, while sparing one’s own (self) tissues. This destructive effect would be beneficial for cancer therapy if it could be directed at tumours.


Bone Marrow Transplantation Center, National Umbilical Cord Blood Bank

The Bone Marrow Transplantation Department at Hadassah Hebrew University Medical Center operates as a national center for bone marrow transplantation and stem-cell-based medicine. The department uses stem cells from various sources including bone marrow, peripheral blood, umbilical cord blood and the placenta.


Red Sea Corals To Treat Skin Cancer

A substance derived from corals has the ability to slow down the growth of cancerous cells as well as induce death of these cells- as shown in a new study.


Nano Israel 2009

NanoIsrael 2009 is a unique event, bringing together a diverse group of elite dynamic speakers and participants. The central showcase for Israel’s excellence in the interdisciplinary world of nanotechnology, NanoIsrael 2009 will bring together industry, academia, investors, non-governmental organizations and government representatives to focus on current research, commercial endeavours and future opportunities in nanotechnology.


Reversing Brain Birth Defects Through Stem Cell Therapy

Scientists at the Hebrew University of Jerusalem have succeeded in reversing brain birth defects in animal models, using stem cells to replace defective brain cells. The work of Prof. Joseph Yanai and his associates at the Hebrew University-Hadassah Medical School was presented at the Tel Aviv Stem Cells Conference last spring and is expected to be presented and published nest year at the seventh annual meeting of the International Society for Stem Cell Research in Barcelona, Spain.


Operation Abraham - Jerusalem AIDS Project.

Operation Abraham is a consortium of institutions committed to the training of local doctors in Africa in the surgical procedures of male circumcision as a method of HIV/AIDS prevention.


Tissue Engineering Will Prevent Bypass Surgeries

A new Israeli technology makes use of genetic engineering to allow the body to produce new blood vessels that can bypass obstructed arteries. A study conducted at Carmel Medical Center suggests that use of tissue engineering will result in an international breakthrough in the field of blood vessel bypasses - a development that may prevent the performance of bypass surgeries in situations of obstructed arteries.


Revelations About Plastic Surgery

Dr. Bianca Rosenberg-Hagen: 'Too Many Face-lifts Can Turn Woman Into Plastic Surgery Cripple! Only Once Or Twice In A Lifetime'

'Sometimes Plastic Surgery To Make People Happy Is Like Saving Their Life - But Some Surgeons Overdo It'

'Israeli Plastic Surgery Enjoys High International Standard'

How many face-lifts should a woman have in her lifetime? How early should a face-lift be conducted? These are just some of the questions discussed by Dr. Bianca Rosenberg-Hagen, a leading Israeli plastic surgeon in a frank and wide ranging interview with IsraCast. Dr. Rosenberg-Hagen, who specialized in plastic-surgery at the Montefiore-Einstein Medical Center in New York, also has timely advice for both men and women, including those with breast cancer.  


Weizmann Institute Scientists Produce The First Smell Map

Is the smell of almonds closer to that of roses or bananas? Weizmann Institute scientists have now answered that question (roses) by showing for the first time that smells can be mapped and the relative distance between various odors determined. Their findings, which appeared recently in Nature Methods, may help scientists to unravel the basic laws underlying our sense of smell, as well as potentially enabling odors to be digitized and transferred via computer in the future.


Help Infants with attachment disorders

The past few years have witnessed a significant increase in the number of children diagnosed with autism, a childhood disorder that affects, language, communication, and social skills. According to the American Health Departments CDC (center for disease control), currently autism affects as many as 1 out of 300 children.


Venus - The next eye in the sky

By the end of the decade a revolutionary new micro-satellite will orbit around the world at an altitude of 700km sending precise information on agriculture and marine changes in unprecedented precision and detail. The Israeli-French project will allow farmers to better treat their crops, fisherman to locate large quantities of fish in mid-sea and will also vastly increase the ability of the scientific community to study and monitor the flora and fauna in many areas around the globe. Equipped with an advanced plasma engine, VENUS will be able to operate for at least 4-5 years in its planed orbit.


Viruses: The new cancer hunters

Researchers from the Hebrew University have succeeded in isolating a variant of the Newcastle Disease Virus (NDV-HUJ), which usually affects birds, in order to specifically target cancer cells. The research, which has already cleared the first phase of clinical trials, is already patented and if all goes well it might receive an approval for clinical use, changing the way we think about viruses forever.